Parkinson's Disease Clinical Trials

Showing 1201-1220 of 1,818 trials

COMPLETEDPhase 1

Dose Escalation Study of Cu(II)ATSM in Parkinson's Disease

NCT03204929

Multicenter, open-label dose-escalation study

Parkinson Disease

Collaborative Medicinal Development Pty Limited31 participantsStarted Aug 2017

Macquarie Park, New South Wales, Australia • Melbourne, Victoria, Australia

COMPLETEDPhase 2

Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients

NCT03162874

This will be a double-blind, randomised, placebo-controlled parallel-arm phase II proof of concept in subjects with PD treated with a stable dose of levodopa who are experiencing both end-of-dose wearing off and Levodopa-Induced Dyskinesia (LID)

Parkinson Disease

Prexton Therapeutics157 participantsStarted Jul 2017

Innsbruck, Austria • Amiens, France • Bayonne, France +42 more locations

Dose Escalation Study of Cu(II)ATSM in Parkinson's Disease

Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients

Related Searches

Falls and Balance of Patients With Parkinson's Disease With Urinary Disturbance

Single Exercise Bout in Parkinson's Disease (PD)

The Impact of a Diagnosis of Parkinson's on Work

Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease

LIPAD - LRRK2 International Parkinson's Disease Study

Rapid Cadence Cycling for Parkinson's Disease: A Study of Implementation and Efficacy in the Community Setting

Diagnosis of Parkinson´s Disease by Means of Submandibular Gland Needle Biopsy

Bioavailability and Bioequivalence Between Two Active Pharmaceutical Ingredient (API) Sources of Opicapone (OPC)

Is Long-term Use of Amantadine Effective in PD?

Improving Walking Ability in Parkinson Disease

A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson

The Effect of Whole Body Vibration in Individuals With Parkinson's Disease

Cerebellar rTMS Theta Burst for Dual-task Walking in Parkinson's Disease

Cerebellar rTMS Theta Burst for Postural Instability in Progressive Supranuclear Palsy

Evaluation of Myocardial Sympathetic Denervation in Parkinson's Disease Using [18F]FDOPA

Pharmacist-led Perioperative Medicines Optimisation

Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease

Study to Evaluate DNL201 in Subjects With Parkinson's Disease